PD
AAPG

Point72 (DIFC)’s Ascentage Pharma AAPG Stock Holding History

Point72 (DIFC)’s Portfolio AAPG Stock Details AAPG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$700K Sell
17,930
-2,960
-14% -$120K 0.05% 230
2025
Q2 		$823K Sell
20,890
-4,514
-18% -$119K 0.03% 453
2025
Q1 		$558K Buy
+25,404
New +$482K 0.02% 616

Other funds holding AAPG

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XC
XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return
NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 (DIFC)'s AAPG Position: Q3 2025 in Review

Point72 (DIFC) reduced its Ascentage Pharma (AAPG) stake by 14% in Q3 2025, selling an estimated $120K and leaving 17,930 shares worth $700K. The position accounts for 0.05% of the portfolio, ranked #230.

Point72 (DIFC) first reported a position in AAPG in Q1 2025 and has held it in 3 quarters since. The position peaked at $823K in Q2 2025. 14 funds tracked by Wall St. Rank hold AAPG as of Q3 2025.

  • Point72 (DIFC) held 17,930 shares of Ascentage Pharma worth $700K as of Q3 2025.
  • Point72 (DIFC) sold 2,960 Ascentage Pharma shares in Q3 2025, an estimated $120K.
  • Ascentage Pharma made up 0.05% of Point72 (DIFC)'s portfolio in Q3 2025, its #230 holding.
  • Point72 (DIFC) first reported a position in Ascentage Pharma in Q1 2025 and has held it in 3 quarters since.
  • Point72 (DIFC)'s Ascentage Pharma position peaked at $823K in Q2 2025.
  • 14 funds tracked by Wall St. Rank held Ascentage Pharma as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.